Jurong Yang

1.3k total citations
40 papers, 984 citations indexed

About

Jurong Yang is a scholar working on Nephrology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jurong Yang has authored 40 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 13 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Jurong Yang's work include Acute Kidney Injury Research (7 papers), Cancer-related molecular mechanisms research (6 papers) and Chronic Kidney Disease and Diabetes (4 papers). Jurong Yang is often cited by papers focused on Acute Kidney Injury Research (7 papers), Cancer-related molecular mechanisms research (6 papers) and Chronic Kidney Disease and Diabetes (4 papers). Jurong Yang collaborates with scholars based in China, United Kingdom and United States. Jurong Yang's co-authors include Xiao‐Ping Zhou, Dan Li, Shun‐Ze Zhan, Quan Hong, Zhe Feng, Changchun Ma, Yan Lin, Zhifen Wu, Mian Li and Jun‐Hao Wang and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Communications and The FASEB Journal.

In The Last Decade

Jurong Yang

38 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jurong Yang China 14 381 183 174 162 136 40 984
Yuchao Lu China 24 528 1.4× 101 0.6× 134 0.8× 37 0.2× 361 2.7× 70 1.6k
Miloslav Dobrota United Kingdom 17 346 0.9× 61 0.3× 61 0.4× 76 0.5× 102 0.8× 44 1.0k
Guo‐Yuan Lu China 15 253 0.7× 131 0.7× 36 0.2× 18 0.1× 113 0.8× 28 621
Na Man China 18 348 0.9× 45 0.2× 185 1.1× 24 0.1× 55 0.4× 26 1.3k
Chunhua Hu China 15 137 0.4× 38 0.2× 32 0.2× 117 0.7× 75 0.6× 46 614
Andréa Carla Bauer Brazil 21 430 1.1× 132 0.7× 67 0.4× 13 0.1× 82 0.6× 72 1.3k
Claudéte J. Valduga Brazil 16 443 1.2× 120 0.7× 108 0.6× 26 0.2× 256 1.9× 28 1.2k
Maki Hasegawa Japan 27 701 1.8× 102 0.6× 58 0.3× 192 1.2× 364 2.7× 68 2.2k

Countries citing papers authored by Jurong Yang

Since Specialization
Citations

This map shows the geographic impact of Jurong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jurong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jurong Yang more than expected).

Fields of papers citing papers by Jurong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jurong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jurong Yang. The network helps show where Jurong Yang may publish in the future.

Co-authorship network of co-authors of Jurong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jurong Yang. A scholar is included among the top collaborators of Jurong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jurong Yang. Jurong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Wang, Jiaxing, et al.. (2023). In silico evidence implicating novel mechanisms of Prunella vulgaris L. as a potential botanical drug against COVID-19-associated acute kidney injury. Frontiers in Pharmacology. 14. 1188086–1188086. 4 indexed citations
4.
Zhao, Lei, et al.. (2023). The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease. Frontiers in Physiology. 14. 1166685–1166685. 21 indexed citations
5.
Li, Lina, et al.. (2023). Comprehensive Management of Blood Pressure in Patients with Septic AKI. Journal of Clinical Medicine. 12(3). 1018–1018. 9 indexed citations
6.
Tan, Wei, et al.. (2022). Pathogenesis and histological changes of nephropathy associated with COVID‐19. Journal of Medical Virology. 95(1). e28311–e28311. 4 indexed citations
7.
Wu, Kunyi, Bo Cao, Shujuan Zhao, et al.. (2022). The C5a/C5aR1 Axis Contributes to the Pathogenesis of Acute Cystitis Through Enhancement of Adhesion and Colonization of Uropathogenic E. coli. Frontiers in Cellular and Infection Microbiology. 12. 824505–824505. 4 indexed citations
8.
Liu, Jing, Xiaozhou Li, Jurong Yang, & Dongshan Zhang. (2022). LncRNA ENSMUST_147219 mediates the progression of ischemic acute kidney injury by targeting the miR-221-5p/IRF6 axis. APOPTOSIS. 27(7-8). 531–544. 16 indexed citations
9.
Wu, Zhifen, et al.. (2022). Programmed Cell Death in Sepsis Associated Acute Kidney Injury. Frontiers in Medicine. 9. 883028–883028. 57 indexed citations
10.
Yang, Jurong, et al.. (2022). Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research. Frontiers in Pharmacology. 13. 932739–932739. 1 indexed citations
11.
Tan, Wei, et al.. (2022). Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products. Frontiers in Pharmacology. 13. 932172–932172. 13 indexed citations
12.
Yu, Rongjie, et al.. (2022). Eosinophilic Granulomatosis With Polyangiitis Presenting With Oral Granuloma as the Initial Symptom: A Case Report. Frontiers in Medicine. 9. 842137–842137. 1 indexed citations
13.
Sun, Yan, et al.. (2020). Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open. 10(11). e042573–e042573. 84 indexed citations
14.
Li, Qinggang, Shaoyuan Cui, Ying Liu, et al.. (2020). ROBO2-mediated RALDH2 signaling is required for common nephric duct fusion with primitive bladder. Developmental Biology. 464(2). 103–110. 2 indexed citations
15.
Li, Qinggang, Shaoyuan Cui, Ying Liu, et al.. (2019). Disruption of Robo2-Baiap2 integrated signaling drives cystic disease. JCI Insight. 4(18). 6 indexed citations
16.
Chen, Dapeng, Ying Li, Yan Mei, et al.. (2014). miR-34a regulates mesangial cell proliferation via the PDGFR-β/Ras-MAPK signaling pathway. Cellular and Molecular Life Sciences. 71(20). 4027–4042. 36 indexed citations
17.
Hong, Quan, Zhe Feng, Shaoyuan Cui, et al.. (2012). Hyperuricemia induces endothelial dysfunction via mitochondrial Na+/Ca2+ exchanger-mediated mitochondrial calcium overload. Cell Calcium. 51(5). 402–410. 96 indexed citations
18.
Gao, Jianjun, Guangyan Cai, Yichun Ning, et al.. (2012). DAP5 Ameliorates Cisplatin-Induced Apoptosis of Renal Tubular Cells. American Journal of Nephrology. 35(5). 456–465. 14 indexed citations
19.
Yang, Jurong, Dapeng Chen, Yani He, et al.. (2011). MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. AGE. 35(1). 11–22. 126 indexed citations
20.
Zhan, Shun‐Ze, Mian Li, Xiao‐Ping Zhou, et al.. (2011). When Cu4I4 cubane meets Cu3(pyrazolate)3 triangle: dynamic interplay between two classical luminophores functioning in a reversibly thermochromic coordination polymer. Chemical Communications. 47(46). 12441–12441. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026